News – Page 83 – Endpoints News

Hospitals gush about new AI note-taking tools. It may leave the human medical scribes who originated the roles behind

6 months ago

Canadian CDMO broadens CGT footprint with new $145M facility

6 months ago

Exclusive: Terray raises $120M for its AI ways of designing molecules

6 months ago

Sage shakes up senior management, slashes pipeline, sheds 33% of staff

6 months ago

Novartis pays $70M upfront to license Chinese biotech’s antitumor drug

6 months ago

Sanofi invests in new radioligand partner Orano Med, buying 16% stake for €300M

7 months ago

Bavarian Nordic's mpox vaccine was safe and spurred promising immune response in children

7 months ago

Compounding association to ask for clarity around tirzepatide's shortage status

7 months ago

First clinical test of RNA editing restores missing protein in genetic disease, Wave says

7 months ago

FDA leaders kick off rare disease hub to increase cross-center collaboration

7 months ago

Exscientia’s $15M milestone from Sanofi; Lilly to take Gateway Labs to China

7 months ago

Medicaid startup Waymark publishes study proving its program slashes ER visits

7 months ago

FDA places hold on Novavax's Covid-flu and standalone influenza vaccines

7 months ago

Facing a critical week, Pfizer confronts an unsparing foe in Starboard

7 months ago

Life sciences investor KdT Ventures raises $100M fund to back new startups

7 months ago

Q&A: Sanofi’s R&D head reflects on his first year, a post-Dupixent future, and finding an identity

7 months ago

Takeda parts ways with Wave Life Sciences even with Huntington’s trial win

7 months ago

Seeking to treat obesity drug side effect, Neurogastrx releases data on drug for GLP-1-associated nausea, vomiting

7 months ago

Sacklers call opioid-related fraud claims 'utterly meritless'

7 months ago

GSK sues Moderna over mRNA vaccine patents, seeks 'reasonable royalty'

7 months ago

Jazz reports Phase 3 success for Zepzelca in first-line maintenance for small cell lung cancer

7 months ago

J&J’s medtech slump continues, improvements not expected until 2025

7 months ago

First patient who received engineered B cell therapy sees early promise for MPS I

7 months ago

J&J trims pipeline, including two mid-stage neuroscience studies

7 months ago

First page Previous page 80 81 828384 85 86 Next page Last page